| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,961,000 | 1,688,000 | 2,255,000 | 2,170,000 | | Cost of Revenue | 1,289,000 | 1,172,000 | 1,551,000 | 1,587,000 | | | Gross Profit | 672,000 | 516,000 | 704,000 | 583,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 63,000 | 58,000 | 80,000 | 75,000 | | Non Recurring |
-
| 3,000 | (3,000) | (18,000) | | Others | 266,000 | 240,000 | 232,000 | 224,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 343,000 | 215,000 | 395,000 | 302,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31,000 | 30,000 | 13,000 | 17,000 | | Earnings Before Interest And Taxes | 374,000 | 245,000 | 408,000 | 319,000 | | Interest Expense | 143,000 | 134,000 | 132,000 | 132,000 | | Income Before Tax | 231,000 | 111,000 | 276,000 | 187,000 | | Income Tax Expense | 73,000 | 27,000 | 97,000 | 57,000 | | Minority Interest | (2,000) | 1,000 | (1,000) | (1,000) | | | | Net Income From Continuing Ops | 158,000 | 85,000 | 178,000 | 129,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 156,000 | 85,000 | 178,000 | 129,000 | | Preferred Stock And Other Adjustments | 2,000 | (2,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $158,000 | $83,000 | $178,000 | $129,000 |
|
0.11% Nasdaq 
0.01%
Income Statement
